Medtrum announced today that it made further progress toward bringing its 300-unit tubeless insulin patch pump to the German market. The company said it delivered a presentation at DDG 2026 in Berlin and was included in Germany’s statutory health insurance medical aids directory for reimbursement purposes. An upcoming German launch expands the company’s presence in […]
Medtrum
Medtrum data highlights time in range with automated insulin delivery system
Medtrum said that a study of its automated insulin delivery (AID) technology demonstrated increased time in range for people with diabetes. In 20 adults with type 1 diabetes, investigators evaluated the performance of the Medtrum A8 TouchCare in AID mode over three months. Findings included more time in range (70-180 mg/dL), increasing from 59.08% to […]
Medtrum touts meal logging tech for automated insulin delivery
Medtrum has shared findings supporting its technology for handling mealtime insulin delivery through its automated system. In a LinkedIn post, the China-based company touted its new solution for eliminating the need for carb counting for people with type 1 diabetes. It hopes to reduce the guesswork in mealtime decisions for people with diabetes, who often […]
Medtrum introduces 300-unit tubeless insulin pump
Medtrum today unveiled the 300-unit version of its TouchCare Nano tubeless automated insulin delivery patch pump. The China-based company took to LinkedIn to announce the advancement: “Tired of your pump running on empty?” the company wrote. “A significant proportion of insulin pump users have TDD requirements, whether due to insulin resistance, body weight, lifestyle, or […]
Report: Insulet trumps Medtrum again in French patent spat
JUVE-Patent reports that the Judicial Court of Paris again ruled in favor of Insulet (Nasdaq:PODD) in its patent battle with Medtrum. According to the report, the court sided with Insulet in a case regarding the company’s patent (EP 1 874 390). The ruling finds that Medtrum’s A6 and A7+ TouchCare insulin pump devices infringe the valid […]
Report: Insulet prevails over Medtrum in France patent spat
According to a report in Europe, a Paris court found that Medtrum’s latest insulin pumps infringe an Insulet (Nasdaq:PODD) patent. JUVE Patent reported that earlier this month, the Judicial Court of Paris declared the infringement. The court found that Medtrum’s newest pump base and patch reservoir models violate the EP2438957B1 patent from Insulet. In declaring […]
